NO971643L - Eterliptid liposomer og terapeutisk anvendelse derav - Google Patents

Eterliptid liposomer og terapeutisk anvendelse derav

Info

Publication number
NO971643L
NO971643L NO971643A NO971643A NO971643L NO 971643 L NO971643 L NO 971643L NO 971643 A NO971643 A NO 971643A NO 971643 A NO971643 A NO 971643A NO 971643 L NO971643 L NO 971643L
Authority
NO
Norway
Prior art keywords
liposomes
etherliptide
therapeutic use
phosphatidylethanolamine
underivatized
Prior art date
Application number
NO971643A
Other languages
English (en)
Other versions
NO316206B1 (no
NO971643D0 (no
Inventor
Eric Mayhew
Andrew Stuart Janoff
Imran Ahmad
Suresh K Bhatia
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of NO971643D0 publication Critical patent/NO971643D0/no
Publication of NO971643L publication Critical patent/NO971643L/no
Publication of NO316206B1 publication Critical patent/NO316206B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO19971643A 1994-10-14 1997-04-10 Eterlipid-liposomer og farmasöytiske sammensetninger av disse NO316206B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32304294A 1994-10-14 1994-10-14
PCT/US1995/012721 WO1996011670A1 (en) 1994-10-14 1995-10-12 Ether lipid liposomes and their therapeutic use

Publications (3)

Publication Number Publication Date
NO971643D0 NO971643D0 (no) 1997-04-10
NO971643L true NO971643L (no) 1997-06-09
NO316206B1 NO316206B1 (no) 2003-12-29

Family

ID=23257529

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19971643A NO316206B1 (no) 1994-10-14 1997-04-10 Eterlipid-liposomer og farmasöytiske sammensetninger av disse

Country Status (15)

Country Link
US (1) US5762958A (no)
EP (1) EP0785773B1 (no)
JP (1) JPH10507450A (no)
KR (1) KR100381449B1 (no)
AT (1) ATE198419T1 (no)
AU (1) AU707414B2 (no)
CA (1) CA2199179A1 (no)
DE (1) DE69519802T2 (no)
DK (1) DK0785773T3 (no)
ES (1) ES2153053T3 (no)
FI (1) FI971494L (no)
GR (1) GR3035689T3 (no)
NO (1) NO316206B1 (no)
PT (1) PT785773E (no)
WO (1) WO1996011670A1 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007839A (en) * 1996-02-16 1999-12-28 The Liposome Company, Inc. Preparation of pharmaceutical compositions containing etherlipid-containing multiple lipid liposomes
US6667053B1 (en) 1996-02-16 2003-12-23 Elan Pharmaceuticals, Inc. D and L etherlipid stereoisomers and liposomes
US5965159A (en) * 1996-02-16 1999-10-12 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US5942246A (en) * 1996-02-16 1999-08-24 The Liposome Company, Inc. Etherlipid containing multiple lipid liposomes
USRE39042E1 (en) * 1996-02-16 2006-03-28 The Liposome Company, Inc. Etherlipid-containing multiple lipid liposomes
US5932242A (en) * 1996-10-15 1999-08-03 The Liposome Company, Inc. Ether lipid-containing pharmaceutical compositions and therapeutic uses thereof
DE19829448A1 (de) * 1998-07-01 2000-10-12 Medmark Pharma Gmbh 1-Octadecyl-2-methyl-sn-glycero-3-phosphocholin (ET180CH3) zur Behandlung von humanen Mammakarzinomen
ES2154560B1 (es) * 1998-09-16 2001-12-01 Lipotec Sa Composicion a base de derivados de cromanos y su uso para reducir quimicamente las reacciones oxidativas o inducidas por radicales libres.
US6583127B1 (en) 1998-12-21 2003-06-24 Inkeysa. Sa Use of etherlysophospholipids as antiinflammatory agents
US8501701B2 (en) 2000-01-10 2013-08-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Use of lipid conjugates in the treatment of disease
US8916539B2 (en) 2000-01-10 2014-12-23 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of disease
US8304395B2 (en) 2000-01-10 2012-11-06 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Lipid conjugates in the treatment of disease
US7772196B2 (en) 2000-01-10 2010-08-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases
US9040078B2 (en) 2000-01-10 2015-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases of the nervous system
US8076312B2 (en) 2000-01-10 2011-12-13 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd Use of lipid conjugates in the treatment of disease
US7608598B2 (en) 2000-01-10 2009-10-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of conjunctivitis
US7893226B2 (en) 2004-09-29 2011-02-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Use of lipid conjugates in the treatment of diseases
US8883761B2 (en) 2001-01-10 2014-11-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Use of lipid conjugates in the treatment of diseases associated with vasculature
JP2008517023A (ja) 2004-10-19 2008-05-22 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ アルキルホスホコリンを含有する新規の負電荷担体を使用した配合物
EA012138B1 (ru) * 2004-11-17 2009-08-28 Йиссум Рисерч Дивелопмент Компани Оф Дзе Хебрю Юниверсити Оф Иерусалим Применение конъюгатов липидов при лечении заболеваний
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
US8859524B2 (en) 2005-11-17 2014-10-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of chronic rhinosinusitis
US8906882B2 (en) 2005-11-17 2014-12-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Lipid conjugates in the treatment of allergic rhinitis
DE102006019907A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von substituierten Glycerinderivaten zur Herstellung einer pharmazeutischen Zubereitung
CA2705785A1 (en) 2006-11-14 2008-05-22 Saul Yedgar Use of lipid conjugates in the treatment of diseases or disorders of the eye
EP2120873B1 (en) * 2006-12-20 2012-06-27 Alphaptose Gmbh Topical dosage form comprising tri-substituted glycerol compounds
ES2594927T3 (es) 2010-02-18 2016-12-23 INSERM (Institut National de la Santé et de la Recherche Médicale) Métodos para prevenir las metástasis cancerosas
US20150132369A1 (en) * 2013-11-09 2015-05-14 Exir Nano Sina Company Nanoliposomal cyclosorin formulations for immunosuppresion and methods for the production thereof
CN114469865B (zh) * 2022-03-17 2023-09-22 中国医学科学院输血研究所 一种与血细胞膜结合的脂质体药物载体及其制备方法和用途
US20260216067A1 (en) 2022-12-15 2026-07-30 Lifesome Therapeutics, S.L. Carrier as a multifunctional system

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2009343C3 (de) * 1970-02-27 1980-10-23 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V., 3400 Goettingen Verwendung von Lysolecithinen als immunologische Adjuvantien
US4163748A (en) * 1973-09-06 1979-08-07 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Propane-1,3-diol phosphatides and method of preparing the same
US4159988A (en) * 1974-08-06 1979-07-03 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Synthetic phospholipids, a process for their manufacture and their use
DE2619686C2 (de) * 1976-05-04 1986-08-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verwendung eines Lysolecithins zur Tumorbehandlung
DE3011738A1 (de) * 1980-03-26 1981-10-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue glycerin-3-phosphorsaeurehalogenalkylester
DE3239858A1 (de) * 1982-07-06 1984-01-12 Max Planck Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Neue d-mannitderivate als ausgangsprodukte zur synthese von phospholipiden
JPS5972294A (ja) * 1982-10-18 1984-04-24 Hisaji Nakamura スピ−カ装置
US4983397A (en) * 1985-08-19 1991-01-08 Board Of Regents, University Of Texas System Pharmaceutical compositions consisting of acylated phospholipids
PH26160A (en) * 1985-08-19 1992-03-18 Univ Texas Pharmaceutical compositions consisting of acylated phospholipids
US4920016A (en) * 1986-12-24 1990-04-24 Linear Technology, Inc. Liposomes with enhanced circulation time
US4965391A (en) * 1987-10-23 1990-10-23 The University Of Michigan Radioiodinated phospholipid ether analogues
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
DE4111105A1 (de) * 1991-04-05 1992-10-08 Max Planck Gesellschaft Neue erucyl-, brassidyl- und nervonylderivate
US5277913A (en) * 1991-09-09 1994-01-11 Thompson David H Liposomal delivery system with photoactivatable triggered release
DE4132345A1 (de) * 1991-09-27 1993-04-01 Max Planck Gesellschaft Ether-lysolecithine und alkylphosphocholine in liposomen
AU2776692A (en) * 1991-10-23 1993-05-21 National Research Council Of Canada Formation of stable liposomes from lipid extracts of archaeobacteria (archaea)
CA2160118A1 (en) * 1993-05-21 1994-12-08 Patrick L. Ahl Reduction of liposome-induced adverse physiological reactions
DE4408011C1 (de) * 1994-03-10 1995-11-02 Max Delbrueck Centrum Pharmazeutisches Mittel zur Tumortherapie

Also Published As

Publication number Publication date
ES2153053T3 (es) 2001-02-16
KR100381449B1 (ko) 2003-07-18
PT785773E (pt) 2001-05-31
GR3035689T3 (en) 2001-07-31
AU3762595A (en) 1996-05-06
DE69519802T2 (de) 2001-04-19
EP0785773B1 (en) 2001-01-03
WO1996011670A1 (en) 1996-04-25
DE69519802D1 (de) 2001-02-08
FI971494A0 (fi) 1997-04-10
FI971494A7 (fi) 1997-04-10
EP0785773A1 (en) 1997-07-30
FI971494L (fi) 1997-04-10
CA2199179A1 (en) 1996-04-25
AU707414B2 (en) 1999-07-08
JPH10507450A (ja) 1998-07-21
NO316206B1 (no) 2003-12-29
DK0785773T3 (da) 2001-01-29
NO971643D0 (no) 1997-04-10
US5762958A (en) 1998-06-09
KR970705378A (ko) 1997-10-09
ATE198419T1 (de) 2001-01-15

Similar Documents

Publication Publication Date Title
DK0785773T3 (da) Etherlipidliposomer og deres terapeutiske anvendelse
DK0783297T3 (da) Polyethylenglycol-modificerede ceramid-lipider og liposomer
MX9606521A (es) Inhibidores de trombina novedosos, preparacion y uso de los mismos.
GR1000074B (el) Λιποειδη σφαιριδια (κυστιδια) για ενδοπεριτονειακη χορηγηση θεραπευτικων παραγοντων.
PT843547E (pt) Metodos para produzir lipossomas contendo contendo um foto-sensibilizador de hidro-monobenzoporfirina
ATE337019T1 (de) Geladene lipide und deren verwendung
EP1355634B8 (en) Sn-38 lipid complexes and methods of use
YU17597A (sh) Konjugati interferona
ES2194114T3 (es) Formulaciones liposomicas de mitoxantrona.
PT758248E (pt) Formulacoes para o factor ix
ES2157344T3 (es) Pirrolo(2,3-d)pirimidinas y su uso.
GT199900019A (es) Formulas farmaceuticamente estables de solucion de oxaliplatino.
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
EA200000274A2 (ru) Способы получения и промежуточные соединения для получения противораковых соединений
DE69324367D1 (de) Kationische lipide
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
TR199700872A3 (tr) Kompleks lipid' lerin kullanilmasi.
ATE232396T1 (de) Oxydiertes thymosin beta 4
ES2191070T3 (es) Arilalquil-piridazinonas.
IT1285770B1 (it) Composti corticoidei
SE9700934D0 (sv) New formulation
ES2145234T3 (es) Derivados de la diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2041617T3 (es) Productos intermedios para agentes de quelacion con simetria prefijada y procedimiento para su preparacion.
NZ335125A (en) Carriers containing an etherlipid/complementarily shape lipid combination and therapeutic uses thereof
ES2192610T3 (es) Aminouracilos substituidos.